Gynecologic oncology at HCG Cancer Hospital, Mumbai, treats the cancers that affect a woman's reproductive system: Cervical cancer, ovarian cancer, uterine cancer (endometrial cancer), vaginal cancer, vulvar cancer, and fallopian tube cancer.
As the best gynecologic oncology hospital in Mumbai, HCG combines specialist surgery, medical oncology, radiation, fertility input, and psychological support under one care team. The unit was set up for women, not adapted for them later.
A cancer diagnosis is rarely just about the tumor. For a woman, it can press on identity, partnership, motherhood, sexuality, and a hundred other things at once. The 32-year-old is newly engaged. The 41-year-old is still hoping for a second child. The 58-year-old was being driven in from Navi Mumbai by a daughter who took the morning off work. They each walk in carrying different weights.
That weight matters in the consultation room. So at HCG Cancer Hospital, Mumbai, the gynecologic oncology team builds the conversation around the woman in front of them, not the cancer printed on her file. Fertility questions get asked early, before treatment locks in. Sexual health gets addressed openly, not buried in a leaflet. Partner counseling is offered. So is family planning support, where it's clinically possible.
The team, gynecologic oncologists, medical oncologists, radiation oncologists, a fertility specialist, reconstructive surgeons, psycho-oncology counselors, and oncology nurses trained specifically in women's cancer pathways, works as one unit. Not five appointments. One plan.
Gynecologic oncology treatment in Mumbai at HCG covers six major cancer groups. Each one moves differently. Each one needs a different conversation.
Cervical and vaginal cancer: Cervical cancer doesn't go quietly in this country, and it doesn't need to. Cervical cancer was among the top three cancers diagnosed in Indian women that year, despite being one of the most preventable through HPV vaccination and screening. Treatment depends on the stage.
Early disease often responds to surgery alone. Locally advanced disease usually needs combined chemoradiation. Vaginal cancer is rarer and more anatomically delicate; treatment plans are made one woman at a time.
Ovarian and fallopian tube cancer: Ovarian cancer hides. The early symptoms, bloating, low pelvic ache, and urinary frequency, sound like a hundred other things, so most women are diagnosed when the disease has already moved beyond the ovaries.
The standard pathway combines debulking surgery (cytoreductive surgery) with chemotherapy. BRCA1 and BRCA2 (Breast Cancer gene 1 and Breast Cancer gene 2) testing is offered because the result changes both the treatment options on the table, PARP (Poly (ADP-ribose) polymerase) inhibitors, and the screening conversation for sisters and daughters.
Uterine and endometrial cancer:Uterine cancer, or endometrial cancer, often shows up in post-menopausal women through abnormal bleeding. Caught early, and most are, surgery can be curative. More advanced cases combine surgery, radiation, and systemic therapy.
Vulvar cancer: It's less common and more under-discussed than it should be. Treatment balances cancer clearance against urinary, sexual, and cosmetic outcomes. Wide local excision with sentinel lymph node biopsy is the modern approach for selected early-stage cases, sparing the heavier morbidity of radical vulvectomy when it's safe to do that.
Diagnostic and Staging Protocols:A solid gynecologic cancer workup runs across five components. Skip any of them, and the picture is incomplete.
Medical history assessment and physical exam:This is where most missed diagnoses get caught. A careful history, including when the symptom started, the pattern, family cancer history, and menstrual and obstetric history, opens up the right next steps. Pelvic examination and bimanual palpation are non-negotiable.
Pap test and HPV testing:Cervical screening through the Pap test, often paired with HPV co-testing, can catch precancerous changes long before they become cancer. Organized cervical cancer screening prevents the majority of cervical cancer deaths globally.
Lab tests:Blood work covers tumor markers (CA-125 for ovarian, CEA (carcinoembryonic antigen), and CA-19-9), a full blood count, and hormone profiles where uterine cancer is suspected. Markers don't diagnose cancer on their own. They support the picture.
Imaging scans: Pelvic ultrasound (transvaginal where indicated), MRI for soft-tissue detail in cervical and uterine cancer, CT for staging, and PET-CT (Positron Emission Tomography - Computed Tomography) to look for distant spread that would change treatment intent. The scan menu is matched to the suspected disease, not handed out as a template.
Biopsy: A tissue sample confirms cancer type, grade, and molecular profile. Endometrial sampling, cervical biopsy, ovarian biopsy at staging surgery, or vulvar punch biopsy; the technique fits the suspected site.
The diagnostic phase has one job. Confirm exactly what the cancer is, exactly where it sits, and exactly how far it's gone before any treatment decision becomes irreversible.
Surgery sits at the center of gynecologic cancer treatment for most patients. The choice of approach depends on tumor type, stage, fertility goals, and the individual woman's clinical picture.
Advanced resections: Total hysterectomy and radical hysterectomy remain core procedures for uterine and cervical cancers. Salpingo-oophorectomy, unilateral or bilateral, is standard for ovarian and fallopian tube cancers. Omentectomy and lymph node removal complete the staging picture in ovarian cancer surgery.
Wide local excision handles selected vulvar and vaginal lesions. Debulking surgery (cytoreductive surgery) for advanced ovarian cancer aims to leave behind no visible disease, a goal that directly shapes how well chemotherapy works afterwards.
The robotic edge: Where it's clinically appropriate, robotic-assisted gynecologic surgery is offered using the da Vinci Robotic System. The pelvis is small and crowded. Conventional laparoscopy reaches its physical limits there sooner than people often realize.
Robotic instruments give the surgeon a wider range of motion and a clearer 3D view of tissue planes, which translates into smaller incisions, lower blood loss, and a shorter hospital stay in suitable cases.
Minimally invasive surgical approaches are an established option for selected early-stage disease, with surgical decisions individualized on a case-by-case basis.
Organ preservation surgery: For young women with early-stage cervical cancer who want to keep the option of pregnancy, radical trachelectomy, removing the cervix while preserving the uterus is discussed during multidisciplinary planning.
Eligibility is strict. Tumor size, grade, lymph node status, and stage all matter. The conversation is honest. Where preservation isn't safe, the team says so plainly.
Reconstructive surgery: Vulvar reconstruction after radical vulvectomy, vaginal reconstruction after pelvic exenteration, and pelvic floor reconstruction are coordinated with reconstructive surgeons during the same surgical planning. The goal is restoring function, not just closing the wound.
Focus on recovery: A structured post-operative plan goes home with every patient. Wound care. Activity restrictions. The warning signs that need urgent review. Follow-up dates. A direct contact line. Recovery scheduling is designed to accommodate what each woman in Mumbai can realistically manage while juggling work, family, and a city commute that doesn't pause for cancer.
Outcome figures are not published until verified by HCG's clinical team. For ovarian cancer, complete cytoreduction, leaving no visible disease behind, is the strongest surgical predictor of long-term outcome, alongside tumor stage and biology.
At HCG Cancer Hospital, Mumbai, every ovarian cancer case is reviewed by the multidisciplinary tumor board to decide whether primary debulking surgery or interval debulking after neoadjuvant chemotherapy gives this patient the best chance.
Fertility preservation during cervical cancer treatment is possible in selected early-stage cases. Radical trachelectomy, removing the cervix while preserving the uterus, is one option for women with small tumors, no lymph node involvement, and a wish to retain pregnancy potential.
The best gynecologic oncology hospital in Mumbai earns that role partly through second-opinion work done well. At HCG Cancer Hospital, Mumbai, second-opinion consultations include independent pathology slide review, fresh imaging assessment, and a multidisciplinary tumor board re-evaluation, not just a verbal review. Patients leave with a written summary covering whether the original plan stands, whether changes are advised, and what those changes mean.
Disclaimer: The specialties and services listed on this page represent the scope of care offered at this unit and are subject to availability. Service availability may vary based on location, staffing, and operational schedule. Consultation with a specialist is required to determine the appropriateness of any service for your individual condition. Please contact the unit directly to confirm current service availability.
Feel free to reach out to us.